1
SECURITIES AND EXCHANGE COMMISSION
-------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) April 27, 2000
Bio-Plexus, Inc.
(Exact Name of Registrant as Specified in Charter)
Connecticut 0-24128 06-1211921
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
129 Reservoir Road, Vernon, CT 06066
(Address of Principal Executive Offices)
Registrant's telephone number, including area code (860) 870-6112
(Former Name or Former Address, if Changed Since Last Report)
2
Item 5. Other Events
Bio-Plexus, Inc. (the "Company") reports that it has named John S. Metz
president and chief executive officer, effective as of April 28, 2000. The press
release related to such appointment is Exhibit 99.1 to this filing, and is
incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIO-PLEXUS, INC.
By: /s/ KIMBERLY A. CADY
--------------------------------
Name: Kimberly A. Cady
Title: Chief Financial Officer and
Vice President of Finance
Date: April 27, 2000
EXHIBIT INDEX
Exhibit No. Description
99.1 Press Release announcing the naming of John S. Metz president
and chief executive officer, effective as of April 28, 2000.